the reductions of cardiac afterload and ventricular filling pressure by nitroprusside appear useful in treatment of severe myocardial failure or infarction , but studies of myocardial cyanide toxicity are needed before complete acceptance of this therapy is warranted .
C0018787
cardiac
C0027061
myocardial